BridgeMD
New treatment option for Atrial Fibrillation
Official title Electrical Cardioversion As a Predictor in Postoperative Preservation of Sinus Rhythm
ClinicalTrials.gov ID: NCT06654401
What this study is testing
- What it's testing
- The aim of this study is to evaluate benefits of electric cardioversion in the early and long-term postoperative period in patients after radiofrequency catheter isolation of pulmonary veins. Parameters of the left atrium will be evaluated by transthoracic echocardiography and electroanatomic mapping.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Informed consent signed by the patient to participate in the study.
- Persistent atrial fibrillation resistant to antiarrhythmic drugs for 6 months or more
- The size of the left atrium is less than 55 mm, volume is less than 130 ml, volume index (LP) is less than 55 ml/m2
You likely can't join if
- Reversible causes of atrial fibrillation (hyperthyroidism, pericarditis, myocarditis).
- Patients in need of myocardial revascularization and/or heart valvular disease correction.
- Any previous intervention (including MAZE surgery, thoracoscopic ablation; implanted occluder of the auricle of the left atrium.).
- Patients with severe concomitant pathology requiring correction.
- Contraindications for administration of anticoagulant therapy.
- Documented presence of a blood clot in the cavity of the left atrium or other reasons preventing the insertion of catheters into the left atrium.
See the full eligibility criteria
- Informed consent signed by the patient to participate in the study.
- Persistent atrial fibrillation resistant to antiarrhythmic drugs for 6 months or more
- The size of the left atrium is less than 55 mm, volume is less than 130 ml, volume index (LP) is less than 55 ml/m2
- Reversible causes of atrial fibrillation (hyperthyroidism, pericarditis, myocarditis).
- Patients in need of myocardial revascularization and/or heart valvular disease correction.
- Any previous intervention (including MAZE surgery, thoracoscopic ablation; implanted occluder of the auricle of the left atrium.).
- Patients with severe concomitant pathology requiring correction.
- Contraindications for administration of anticoagulant therapy.
- Documented presence of a blood clot in the cavity of the left atrium or other reasons preventing the insertion of catheters into the left atrium.
- BMI of 40 or more
The study team makes the final eligibility decision.
Where it's taking place
- Saint Petersburg, Sankt-Peterburg, Russia
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Saint Petersburg, Sankt-Peterburg, Russia. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.